[@b1-ehp-119-a158a] estimated the global burden of respiratory mortality attributable to long-term ozone exposure based on a single observational study by [@b3-ehp-119-a158a]. Because no other study has clearly demonstrated impacts of chronic ozone exposure on deaths from respiratory-related causes, we believe that reliance on the study by Jerrett et al. to establish causality and global impact is misplaced and that the conclusions of Anenberg et al. are likely unfounded.

[@b3-ehp-119-a158a] carried out a follow-up analysis of the American Cancer Society (ACS) cohort. Other ACS studies reported no associations between long-term ozone exposure and cardiopulmonary mortality that are robust to model inclusion of co-pollutants (e.g., [@b5-ehp-119-a158a]; [@b6-ehp-119-a158a]). In addition, other long-term studies of ozone-related respiratory or cardiopulmonary mortality did not report positive associations ([@b2-ehp-119-a158a]; [@b4-ehp-119-a158a]). [@b1-ehp-119-a158a] suggested that long-term respiratory mortality is plausible because short-term ozone mortality has been documented, but inconsistent evidence for an association between short-term ozone exposure and respiratory mortality indicates that this relationship is not well established.

[@b3-ehp-119-a158a] did not provide "clear" evidence of an association between long-term ozone exposure and respiratory mortality, as [@b1-ehp-119-a158a] stated in their article. [@b3-ehp-119-a158a] did not adequately control for potential confounding effects of particulate matter ≤ 2.5 μm in aerodynamic diameter (PM~2.5~) for several reasons. [@b3-ehp-119-a158a] used only 2 years of data for PM~2.5~ (1999--2000) but ozone concentrations from 1977--2000. Although ozone and PM~2.5~ levels decreased considerably from 1977 to 2000, they used higher ozone levels observed in the past but only the more recent PM~2.5~ levels. Furthermore, their ozone metric focused on daily maximum hourly levels in the warm seasons, whereas they used annual average PM~2.5~ concentrations. As noted by [@b3-ehp-119-a158a], this approach likely increased the potential to observe an association between ozone and mortality and decreased the ability to observe potential PM~2.5~ confounding of this association. In addition, confounding by other co-pollutants (e.g., sulfur dioxide), a clear issue in earlier ACS analyses ([@b5-ehp-119-a158a]), was not examined. Accordingly, Jerrett et al. did not demonstrate an association between ozone and respiratory mortality that is independent of other co-pollutants.

Another aspect of the [@b3-ehp-119-a158a] study that is inconsistent with an association between long-term ambient ozone exposure and respiratory mortality is the biologically implausible, inverse associations of ozone with cardiovascular and all-cause mortality. The magnitude of these associations is the same---although opposite in direction---as the risk estimate for respiratory mortality; thus, it is likely that associations of this magnitude are not indicative of a causal relationship.

It was inappropriate for [@b3-ehp-119-a158a] to combine data across cities for a U.S. national risk estimate, given the known geographic heterogeneity of ozone-mortality findings ([@b2-ehp-119-a158a]). In addition, socioeconomic data (a potential confounder) was collected in 1982--1983 for the ACS study but never updated. For these reasons, the U.S. national risk estimate reported by [@b3-ehp-119-a158a] should not be extrapolated globally.

The analysis by [@b1-ehp-119-a158a] was based on an uncorroborated study that likely misinterpreted the findings regarding ozone effects. The utility of estimating the global burden of an effect based on a single study, for which no causal association has been established in other studies, is not apparent. Conclusions drawn from such an analysis should be interpreted with caution.
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